K. Watenpaugh

发表

The Cyclin-dependent Kinases cdk2 and cdk5 Act by a Random, Anticooperative Kinetic Mechanism*

K D Watenpaugh, P. Clare, R. Poorman, 2001, The Journal of Biological Chemistry.

Cation binding to the integrin CD11b I domain and activation model assessment.

B. Finzel, R. Heinrikson, N. Horton, 1998, Structure.

Refinement of the model of a protein: rubredoxin at 1.5 Å resolution

K. D. Watenpaugh, L. Sieker, K. Watenpaugh, 1973 .

Structure-based design of HIV protease inhibitors: 5,6-dihydro-4-hydroxy-2-pyrones as effective, nonpeptidic inhibitors.

B C Finzel, K D Watenpaugh, W. Howe, 1996, Journal of medicinal chemistry.

The atomic-resolution structure of human caspase-8, a key activator of apoptosis.

A. Tomasselli, R. Heinrikson, K. Watenpaugh, 1999, Structure.

Crystallization of purified recombinant human interleukin‐1β

H. M. Einspahr, Donald B. Carter, K. D. Watenpaugh, 1988, Proteins.

Structures and comparison of the Y98H (2.0 A) and Y98W (1.5 A) mutants of flavodoxin (Desulfovibrio vulgaris).

K. Watenpaugh, W. Watt, R. Reynolds, 2001, Acta crystallographica. Section D, Biological crystallography.

Use of medium-sized cycloalkyl rings to enhance secondary binding: discovery of a new class of human immunodeficiency virus (HIV) protease inhibitors.

W. Howe, B. Finzel, K. Watenpaugh, 1995, Journal of medicinal chemistry.

Crystal structure of recombinant human interleukin-1 beta at 2.0 A resolution.

D. R. Holland, B. Finzel, S. Muchmore, 1989, Journal of molecular biology.

Crystal forms of a lysine-49 phospholipase A2 from the eastern cottonmouth snake

D. R. Holland, B. Finzel, S. Muchmore, 1990 .

Crystallization of recombinant human interleukin 1β

J. Paslay, S. Muchmore, I. Reardon, 1988 .

CRYSTAL STRUCTURE OF RECOMBINANT HUMAN INTERLEUKIN-1BETA AT 2.0 ANGSTROMS RESOLUTION

B. Finzel, K. Watenpaugh, H. Einspahr, 1990 .

The Structure of a Non-Heme Iron Protein: Rubredoxin at 1.5 Å Resolution

L. Sieker, K. Watenpaugh, L. H. Jensen, 1972 .

The structure of a non-heme iron protein: rubredoxin at 1.5 Angstrom resolution.

L. Sieker, K. Watenpaugh, L. H. Jensen, 1972, Cold Spring Harbor symposia on quantitative biology.

Crystal and Molecular Structure of Adenosine 3',5'-Cyclic Phosphate

K. Watenpaugh, L. H. Jensen, S. Furberg, 1968, Science.

Structure-based design of novel HIV protease inhibitors: carboxamide-containing 4-hydroxycoumarins and 4-hydroxy-2-pyrones as potent nonpeptidic inhibitors.

K D Watenpaugh, W. Howe, A. Tomasselli, 1995, Journal of medicinal chemistry.

NH---S hydrogen bonds in Peptococcus aerogenes ferredoxin, Clostridium pasteurianum rubredoxin, and Chromatium high potential iron protein.

K. Watenpaugh, L. H. Jensen, E. Adman, 1975, Proceedings of the National Academy of Sciences of the United States of America.

Comparison of the crystal structures of a flavodoxin in its three oxidation states at cryogenic temperatures.

K D Watenpaugh, A. Tulinsky, K. Watenpaugh, 1993, Journal of molecular biology.

Crystal and molecular structure of .mu.-oxo-bis[chloro-bis(2,4-pentanedionato)titanium(IV)]-chloroform, [TiCl(C5H7-O2)2]2O.CHCl3

K. Watenpaugh, C. N. Caughlan, 1967 .

Tipranavir (PNU-140690): a potent, orally bioavailable nonpeptidic HIV protease inhibitor of the 5,6-dihydro-4-hydroxy-2-pyrone sulfonamide class.

K D Watenpaugh, K. Watenpaugh, R. Tommasi, 1998, Journal of medicinal chemistry.

Structure-based design of nonpeptidic HIV protease inhibitors: the sulfonamide-substituted cyclooctylpyramones.

K D Watenpaugh, W. Howe, D. Anderson, 1997, Journal of medicinal chemistry.

Structure-based design of HIV protease inhibitors: sulfonamide-containing 5,6-dihydro-4-hydroxy-2-pyrones as non-peptidic inhibitors.

W. Howe, K. Watenpaugh, F. Schwende, 1996, Journal of medicinal chemistry.

Structure-based design of HIV protease inhibitors: 4-hydroxycoumarins and 4-hydroxy-2-pyrones as non-peptidic inhibitors.

K D Watenpaugh, W. Howe, K. Watenpaugh, 1994, Journal of medicinal chemistry.

Non-peptidic HIV protease inhibitors: C2-symmetry-based design of bis-sulfonamide dihydropyrones.

K. Watenpaugh, R. Tommasi, M. Janakiraman, 1998, Bioorganic & medicinal chemistry letters.

The Crystal and Molecular Structure of Dichlorodiphenoxytitanium(IV)

K. Watenpaugh, C. N. Caughlan, 1966 .

The Crystal and Molecular Structure of Methyl Vanadate, VO(OCH3)3

H. M. Smith, K. Watenpaugh, C. N. Caughlan, 1966 .

The structure of rubredoxin at 1.2 A resolution.

L. Sieker, K. Watenpaugh, L. H. Jensen, 1979, Journal of molecular biology.

Structure-based design of sulfonamide-substituted non-peptidic HIV protease inhibitors.

W. Howe, K. Watenpaugh, M. Janakiraman, 1995, Journal of medicinal chemistry.

Structure-based design of nonpeptidic HIV protease inhibitors from a cyclooctylpyranone lead structure.

K D Watenpaugh, W. Howe, K. Watenpaugh, 1995, Journal of medicinal chemistry.

The Binding of Riboflavin-5′-Phosphate in a Flavoprotein: Flavodoxin at 2.0-Å Resolution

L. Sieker, K. Watenpaugh, L. H. Jensen, 1973 .

Crystallization of the NAD-dependent malic enzyme from the parasitic nematode Ascaris suum.

D. R. Holland, B. Finzel, S. Muchmore, 1992, Journal of Molecular Biology.

Structures of Two Non-Haem Iron Proteins: Rubredoxin at 0.15 nm (1.5Å) Resolution and Ferredoxin at 0.20 nm (2.0Å) Resolution

L. Sieker, K. Watenpaugh, L. H. Jensen, 1973 .

Water structure in a protein crystal: rubredoxin at 1.2 A resolution.

L. Sieker, K. Watenpaugh, L. H. Jensen, 1978, Journal of molecular biology.

The crystallographic structure of the protease from human immunodeficiency virus type 2 with two synthetic peptidic transition state analog inhibitors.

A. Tomasselli, R. Heinrikson, K. Watenpaugh, 1993, The Journal of biological chemistry.

Classification and use of macromolecular data

Philip E. Bourne, John D. Westbrook, Helen M. Berman, 2006 .

Crystal structure of the catalytic subunit of Cdc25B required for G2/M phase transition of the cell cycle.

K D Watenpaugh, K. Watenpaugh, M R Deibel, 1999, Journal of molecular biology.

The crystal structure of a lysine 49 phospholipase A2 from the venom of the cottonmouth snake at 2.0-A resolution.

D. R. Holland, B C Finzel, K D Watenpaugh, 1994, The Journal of biological chemistry.

Macromolecular dictionary (mmCIF)

Philip E. Bourne, John D. Westbrook, Helen M. Berman, 2006 .

Crystallographic refinement of rubredoxin at 12 resolution

K. D. Watenpaugh, L. Sieker, K. Watenpaugh, 1980 .

Overview of phasing by isomorphous replacement.

K. Watenpaugh, 1985, Methods in enzymology.

Crystal structure of recombinant human interleukin-1β at 2·0 Å resolution

Barry C. Finzel, Howard M. Einspahr, D. R. Holland, 1989 .

Structure of the oxidized form of a flavodoxin at 2.5-Angstrom resolution: resolution of the phase ambiguity by anomalous scattering.

L. Sieker, K. Watenpaugh, J. Legall, 1972, Proceedings of the National Academy of Sciences of the United States of America.

[30] Macromolecular crystallographic information file

Philip E. Bourne, John D. Westbrook, Helen M. Berman, 1997 .

Macromolecular Crystallographic Information File.

P E Bourne, H M Berman, K D Watenpaugh, 1997, Methods in enzymology.

Crystallographic refinement of rubredoxin at 1 x 2 A degrees resolution.

L. Sieker, K. Watenpaugh, L. H. Jensen, 1985, Journal of molecular biology.

The Macromolecular Crystallographic Information File (mmCIF)

Philip E. Bourne, Helen M. Berman, Brian McMahon, 2001 .

A model of the complex between cyclin-dependent kinase 5 and the activation domain of neuronal Cdk5 activator.

K D Watenpaugh, K. Chou, R. Heinrikson, 1999, Biochemical and biophysical research communications.

Hydrogen bonds in Peptococcus aerogenes ferredoxin , Clostridium pasteurianum rubredoxin , and Chromatium high potential iron

K. Watenpaugh, L. H. Jensen, E. Adman, 2022 .

Structure-based design of novel HIV protease inhibitors: sulfonamide-containing 4-hydroxycoumarins and 4-hydroxy-2-pyrones as potent non-peptidic inhibitors.

K. Watenpaugh, M. Janakiraman, K. Chong, 2010, Journal of Medicinal Chemistry.

Applications of synchrotron radiation to protein crystallography. II. Anomalous scattering, absolute intensity and polarization

K. Hodgson, A. Wlodawer, J. C. Phillips, 1977 .

A limited-range step-scan method for collecting X-ray diffraction data

L. Sieker, K. Watenpaugh, L. H. Jensen, 1979 .

Macromolecular crystallography at cryogenic temperatures: Current Opinion in Structural Biology 1991, 1: 1012–1015

Keith D. Watenpaugh, K. Watenpaugh, 1991 .

32 – The Crystal Structure of Human Interleukin-1α

D. R. Holland, B. Finzel, S. Muchmore, 1990 .

Flavodoxin from the Sulfate Reducing Bacterium Desulfovibrio vulgaris. Its Structure at 2.5 A Resolution

L. Sieker, K. Watenpaugh, L. H. Jensen, 1972, Zeitschrift fur Naturforschung. Teil B. Anorganische Chemie, organische Chemie, Biochemie, Biophysik, Biologie.

Sequence of rubredoxin by x-ray diffraction.

L. Sieker, K. Watenpaugh, L. H. Jensen, 1973, Journal of molecular biology.